Standing tall in bright red hazmat suits, five North Korean health workers stride towards an ambulance to do battle with a COVID-19 outbreak that – in the presumed absence of vaccines – the country is using antibiotics and home remedies to treat. The isolated state is one of only two countries yet to begin a vaccination campaign and, until last week, had insisted it was COVID-free. Now North Korea is mobilizing forces including the army and a public information campaign to combat what authorities have acknowledged is an “explosive” outbreak.
Universal Antivirals Could be the Future for Preventing Pandemics
Acute Respiratory Distress Syndrome (ARDS), Antivirals, BioSpace, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19), Drug Supply Chain, Immune System, Influenza, Pandemics, Pneumonia, R&D, Respiratory Syncytial Virus (RSV) Infection, Vaccines, VirusesSince the emergence of the COVID-19 pandemic, there has been increased interest in developing a universal antiviral that would stop a pandemic in its tracks.
Pharmacy chains should pay $878 million for opioid epidemic role, Ohio counties say
CVS Health, Legal, Ohio, Opioid Epidemic, Opioid Litigation, Opioid Overdoses, Opioid Prescriptions, Opioid Safety, Opioids, Opioids, Overdoses, Prescriptions, Public Health Emergencies, Retail Pharmacies, Therapeutics, Wal-Mart Stores, Walgreens Boots AllianceA lawyer for two Ohio counties said CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. should fund an $878 million plan to address the opioid crisis there, as a first-of-its-kind trial got underway to determine the pharmacy chains’ contribution.
Teva Pharm expects U.S. opioid case settlements to cost $2.6 billion
Analysts, Blockbusters, Business, Europe, Florida, Generics, Legal, Multiple Sclerosis, North America, Opioid Epidemic, Opioid Litigation, Quarterly results, Rhode Island, Sales, San Francisco, Settlements, Shares, Teva, Therapeutics, West VirginiaTeva Pharmaceutical Industries believes the company would have to pay around $2.6 billion in cash and medicine to settle thousands of lawsuits alleging the world’s largest generic firm and other drug manufacturers fueled the U.S. opioid epidemic.
Opioid distributors reach $518 million settlement with Washington state
Allegations, AmerisourceBergen, Business, Cardinal Health, Class Action Lawsuits, Drug Distributors, Epidemics, Hydrocodone, Johnson & Johnson, Lawsuits, Legal, McKesson, Opioid Epidemic, Opioid Overdoses, Opioids, Opioids, Settlements, Therapeutics, U.S. Centers for Disease Control and Prevention, WashingtonWashington reached a $518 million settlement with drug distributors McKesson Corp., AmerisourceBergen Corp. and Cardinal Health, ending a months-long trial over the companies’ alleged role in fueling the opioid epidemic in the state, the three companies announced on May 3.
Eli Lilly’s lucrative Q1 2022 driven by Trulicity and COVID-19 antibodies
Alzheimer’s disease, Bamlanivimab (LY-CoV555), Bebtelovimab (LY-CoV1404; LY3853113), Business, COVID-19 Antibodies, Diabetes, Diabetes drugs, Earnings per share (EPS), Eli Lilly, Etesevimab (Lilly), Financials, Forecasts, Obesity, Obesity, Sales, Therapeutics, TrulicityEli Lilly had a lucrative first-quarter 2022, with revenue growth rising 15 percent driven by sales of the company’s diabetes drug Trulicity and its COVID-19 antibodies.
Walgreens, Teva face San Francisco trial over opioid epidemic
Alabama, AmerisourceBergen, Business, California, Cardinal Health, Drug Distributors, Endo, Epidemics, Johnson & Johnson, Lawsuits, Lawsuits, Los Angeles, McKesson, Opioid Lawsuits, Opioids, Opioids, Pharmacies, Pharmacy, Purdue Pharma, San Francisco, Therapeutics, U.S. Opioid Crisis, Walgreens Boots Alliance, West VirginiaSan Francisco squared off on April 25 against Walgreens Boots Alliance and three other companies accused of fueling an opioid crisis in the city, the first trial to target manufacturers, distributors and pharmacies over the addictive pain medicines.
Fentanyl overdoses are now the top cause of death among U.S. residents ages 18-45, surpassing suicide, car accidents and COVID, according to an analysis of federal data by opioid awareness organization Families Against Fentanyl. To prevent such deaths, FentCheck’s co-founders and a team of volunteers regularly visit a network of businesses in Oakland, San Francisco, New York and Philadelphia to replenish stocks of the test strips.
McKinsey & Company, a consulting firm that covers multiple industries including healthcare and life sciences, is under fire for allegedly allowing its employees to work simultaneously for big pharma companies and serve as consultants for the U.S. Food and Drug Administration.
West Virginia Says J&J, Drugmakers Created ‘Tsunami’ of Opioid Addiction
AbbVie, Addictions, Allergan, Business, Class Action Lawsuits, Johnson & Johnson, Lawsuits, Lawsuits, Opioid Lawsuits, Opioid Overdoses, Opioids, Opioids, Opioids, Opioids, Overdoses, Painkillers, Public Health Crisis, Settlements, Teva, Therapeutics, West VirginiaWest Virginia’s attorney general on April 4 urged a judge to hold Johnson & Johnson, Teva Pharmaceutical Industries Ltd., and AbbVie Inc.’s Allergen liable for causing a “tsunami” of opioid addiction in the state.